@merridew
... suspect we are under-immjnising; boosting here, and our interests would be better served by assisting more distant neighbours more.
midgephoto
@merridew sounds fair. Potential, easily available.
Someone might chip in at this point, noting the suggested rate, to ask if we can think of anything else to spend G£400 on that might be more useful.
And most of us would point to some sort of crossover, applying some resources to this and some to (those) other things.
And then there are the loonies, quacks, and horrors with their views, but enough of them.
I suspect ...
@merridew
...There are many things we could do, many of which are good or at least not bad, and deciding how much of each we do is a strange business.
I think resource allocation and deployment could be done better, but I don't have ambitions as planetary overlord or whatever.
A while after I was born there were 4 billion of us*, and soon there will be 9 billion. Some things we should be able to do much more of and better, some we do, and some things we may need to share more widely.
* ish
@merridew Interesting paper. On COVID I didn't see the 4 billion in there, but I didn't do adding up, either.
I've ignored all the vaccines that are not mRNA for assorted reasons, but they must be potentially useful still.
On Influenza, I think the capacity is greatly more than that, but much of it is potential and/or used for other purposes. Given a 1919-like strain we could ramp it up rapidly.
@merridew You might find it helpful to see this as lining up the whole population, of the world, in ranks, ordered by how useful or urgent it is to immunise them.
You have enough doses for fewer ranks than are there. You have more doses of flu vaccine than of COVID.
In what order have you put your ranks?
Are the ranks identical for the 2 (and several other) vaccines?
You may care to imagine being in rank n+1
Why should you be swapped with someone in rank n?
@fakeman_pretendname @merridew
None of them are £0
We buy them in bulk, and pay for most through general taxation, efficiently.
The COVID vaccines are made by actually more expensive and difficult techniques/ologies, which are available in new facilities of more limited extent.
Expect the products of those techs to become more plentiful and cheaper, and the difference may get below the order of magnitude. Not to parity.
@HikuNoir @Emperor
Gargle with some if you like.
You may care to consider that nerve agents, as with other war gases, are optimised to be lethal or disabling on exposure after deployment, and then decay, allowing occupation of territory etc.
You may also care to consider the targetting of the agent in these particular instances, and the availability of high-quality intensive care facilities.
@sturmblast @Mex
Freedom has costs: fitting a silencer or using a quiet vehicle is not a big deal.